|
Feb 24
|
Stryker grows cardiovascular division with Inari Medical acquisition
|
|
Feb 20
|
Stryker concludes Inari Medical acquisition for $4.9bn
|
|
Feb 19
|
Inari Medical, Inc. (NARI): the Best Performing Healthcare Stock So Far in 2025
|
|
Feb 13
|
Kadant Set to Join S&P SmallCap 600
|
|
Jan 3
|
Reasons to Retain Inari Medical Stock in Your Portfolio for Now
|
|
Jan 3
|
Inari Medical to Present at the J.P. Morgan Healthcare Conference
|
|
Oct 9
|
Inari Medical Inc (NARI) Q2 2024 Earnings Call Highlights: Record Revenue Growth Amidst Challenges
|
|
Oct 7
|
Inari Medical to Host Analyst and Investor Meeting Following PEERLESS RCT Presentation
|
|
Oct 7
|
Inari Medical to Announce Third Quarter 2024 Financial Results
|
|
Aug 29
|
Inari Medical Announces PEERLESS Data to be Presented During the Late-Breaking Clinical Trial Sessions at TCT 2024
|
|
Aug 27
|
Inari updates label of clot removal device linked to 6 deaths
|
|
Aug 26
|
FDA Classifies Recall Of Inari Medical's Large Vessel Clot Removal Catheter Device As Most Serious
|
|
Aug 26
|
Inari Medical (NARI) Issues Notice Post ClotTriever XL Recall
|
|
Aug 2
|
The Inari Medical, Inc. (NASDAQ:NARI) Second-Quarter Results Are Out And Analysts Have Published New Forecasts
|
|
Aug 2
|
Inari promotes Kevin Strange to CFO
|
|
Aug 1
|
Inari Medical Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
|
Jul 31
|
Inari Medical (NARI) Q2 Earnings Miss, Revenues Increase Y/Y
|
|
Jul 30
|
Inari Medical, Inc. (NARI) Reports Q2 Loss, Tops Revenue Estimates
|
|
Jul 30
|
Inari Medical Announces Chief Financial Officer Retirement and Succession Plan
|
|
Jul 30
|
Inari Medical Reports Second Quarter 2024 Financial Results
|